Ушбу ишга иқтибос қилган ишлар

2 та иш

Иш: U.S. Regulatory Considerations for Development of Live Biotherapeutic Products as Drugs

1. The emerging microbiome‐based approaches to <scp>IBD</scp> therapy: From <scp>SCFAs</scp> to urolithin A

   Mohammad Rudiansyah, Saade Abdalkareem Jasim, Bakhadir S. Azizov +9

   Шарҳ мақолаInflammatory Bowel DiseaseJournal of Digestive Diseases20220 иқтибос

   ABIABI:AkademIndex/openalex/2022.review-article.000031

2. ADVANCES IN PROBIOTIC DEVELOPMENT AND PARAMETERS FOR PHASE II CLINICAL TRIALS

   E.Zh. SHORABAEV, I.A. RATNIKOVA, S.E. ORAZYMBET +2

   МақолаProbiotics and Fermented FoodsМИКРОБИОЛОГИЯ ЖӘНЕ ВИРУСОЛОГИЯ20260 иқтибос

   ABIABI:AkademIndex/openalex/2026.article.008657